HIV-1-induced perturbations of glycosphingolipid metabolism are cell-specific and can be detected at early stages of HIV-1 infection

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 19, Issue 3, 1998, Pages 221-229

  Fantini, Jacques ^a,b   Tamalet, Catherine ^a   Hammache, Djilali ^a   Tourrès, Christian ^a   Duclos, Nathalie ^a   Yahi, Nouara ^a  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

AIDS; Gangliosides; Glycolipids; HIV; Metabolism

Indexed keywords

GALACTOSE; GANGLIOSIDE GM3; GLOBOTRIAOSYLCERAMIDE; GLYCOSPHINGOLIPID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID METABOLISM; MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHROMATOGRAPHY, THIN LAYER; FEMALE; G(M3) GANGLIOSIDE; GLYCOSPHINGOLIPIDS; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MALE; TRIHEXOSYLCERAMIDES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032213018     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199811010-00003     Document Type: Article

References (42)

1. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183-289.
2. Cloyd MW, Moore BE. Perturbation of host-cell membrane is a primary mechanism of HIV pathology. Virology 1991;181:500-11.
3. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992;175:331-40.
4. Aguilar JJ, Anel A, Torres J, Semmel M, Uriel J. Changes in lipid composition of huma peripheral blood lymphocytes infected by HIV. AIDS Res Hum Retroviruses 1991;7:761-5.
5. + cells. AIDS 1992;6:332-3.
6. Aloia RC, Tian H, Jensen FC. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membrane. Proc Natl Acad Sci USA 1993;90:5181-5.
7. Matsuda K, Taki T, Hamanaka S, et al. Glycosphingolipid compositions of human T-lymphotropic virus type I (HTLV-I) and human immunodeficiency virus (HIV)-infected cell lines. Biochim Biophys Acta 1993;1168:123-9.
8. Thompson TE, Tillack TW. Organization of glycosphingolipids in bilayers and plasma membranes of mammalian cells. Annu Rev Biophys Biophys Chem 1985;14:361-86.
9. Hakomori S-I, Igarashi Y. Functional role of glycosphingolipids in cell recognition and signaling. J Biochem 1995;118:1091-103.
10. Taga S, Tétaud C, Mangeney M, Tursz T, Wiels J. Sequential changes in glycolipid expression during human B cell differentiation: enzymatic bases. Biochim Biophys Acta 1995;1254:56-65.
11. Yuasa H, Scheinberg DA, Houghton AN. Gangliosides of T lymphocytes: evidence for a role in T-cell activation. Tissue Antigens 1990;36:47-56.
12. Misasi R, Sorice M, Griggi T, et al. GM3 as a target of antilymphocytic ganglioside antibodies in AIDS patients. Clin Immunol Immunopathol 1993;67:216-23.
13. Griggi T, Bauer R, Garofalo T, et al. Autoantibodies against ganglioside GM3 represent a portion of anti-lymphocyte antibodies in AIDS patients. Scand J Immunol 1994;40:77-82.
14. Sorice M, Garofalo T, Sansolini T, et al. Overexpression of monosialoganglioside GM3 on lymphocyte plasma membrane in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:112-9.
15. Leoni LM, Losa GA. Changes in membrane enzymes and glycosphingolipids in lymphocytes from HIV-1-infected and noninfected intravenous drug users. J Acquir Immune Defic Syndr Hum Retroviml 1996;11:188-97.
16. Lu Y, Sharom FJ. Gangliosides are potent immunosuppressors of IL-2 mediated T-cell proliferation in a low protein environment. Immunology 1995;86:356-63.
17. Whishler RL, Yates AJ. Regulation of lymphocyte responses by human gangliosides. I. Characteristics of inhibitory effects and the induction of impaired activation. J Immunol 1980;125:2106-11.
18. - cells by two distinct mechanisms. Proc Natl Acad Sci USA 1995; 92:4867-71.
19. Yahi N, Fantini J, Mabrouk K, et al. Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages. J Virol 1994;68:5714-20.
20. Rouzioux C, Puel J, Agut H, et al. Comparative assessment of quantitative HIV viraemia assays. AIDS 1992;6:373-7.
21. Barré-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-71.
22. Collman R, Balliet JW, Gregory, SA, et al. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of HIV. J Virol 1992;66:7517-21.
23. Yahi N, Spitalnik SL, Stefano KA, De Micco P, Gonzalez-Scarano F, Fantini J. Interferon-τ decreases cell surface expression of galactosyl ceramide, the receptor for HIV-1 gp120 on human colonie epithelial cells. Virology 1994;204:550-7.
24. Spitalnik PF, Danley JM, Burger SR, Spitalnik SL. The glycosphingolipid composition of the human hepatoma cell line, Hep-02. Arch Biochem Biophys 1989;273:578-91.
25. Stein KE, Marcus DM. Glycosphingolipids of purified human lymphocytes. Biochemistry 1977;16:5285-91.
26. Macher BA, Klock JC, Fukuda MN, Fukuda M. Isolation and structural characterization of human lymphocyte and neutrophil gangliosides. J Biol Chem 1981;256:1968-74.
27. Symington FW, Hakomori S-I. Glycosphingolipids of immune cells. Lymphokines 1985;12:201-38.
28. Kiguchi K, Henning-Chubb CB, Huberman E. Glycosphingolipid patterns of peripheral Wood lymphocytes, monocytes, and granulocytes are cell specific. J Biochem 1990;107:8-14.
29. Yamashiro S, Okada M, Haraguchi M, et al. Expression of α2,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation in activated T lymphocytes. Glycoconjugate J 1995;12:894-900.
30. Newburg DS, Chaturvedi P, Lopez EL, Devoto S, Fayad A, Cleary TG. Susceptibility to hemolytic-uremic syndrome relates to erythrocyte glycosphingolipid patterns. J infect Dis 1993;168:476-9.
31. Dawson G, Matalon R, Dorfman A. Glycosphingolipids in cultured human skin fibroblasts. I. Characterization and metabolism in normal fibroblasts. J Biol Chem 1972;247:5944-50.
32. Ruhlig MA, Person S. Alterations of neutral glycolipids in cells infected with syncytium-producing mutants of Herpes simplex virus type 1. J Virol 1977;24:602-8.
33. Mizutamari RK, Wiegandt H, Nores GA. Characterization of antiganglioside antibodies present in normal plasma. J Neuroimmunol 1994;50:215-20.
34. Ladisch S, Becker H, Ulsh L. Immunosuppression by human gangliosides. I. Relationship of carbohydrate structure to the inhibition of T cells responses. Biochim Biophys Acta 1992;1125:180-8.
35. Stricker RB, McHugh TM, Morrow WJW, et al. An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4 T cells. Nature 1987;327:710-3.
36. Berenson CS, Patterson MA, Pattoli MA, Murhy TF. A monoclonal antibody to human macrophages gangliosides inhibits macrophage migration. J Leukocyte Biol 1996;59:371-9.
37. Schroder EW, Merrick JM. Alterations in glycosphingolipid patterns in a line of African green monkey kidney cells infected with Herpesvirus. J Virol 1979;32:734-40.
38. Van Veldhoven PP, Matthews TJ, Bolognesi DP, Bell RM. Changes in bioactive lipids, alkylglycerol and ceramide, occur in HIV-infected cells. Biochem Biophys Res Commun 1992;187:209-16.
39. Saito M, Terui Y, Nojiri H. An acidic glycosphingolipid, monosialo-ganglioside GM3, is a potent physiological inducer for monocytic differentiation of human promyelocytic leukemia cell line HL-60 cells. Biochem Biophys Res Commun 1985;132:223-31.
40. Nojiri H, Takaku F, Terui Y, Miura Y, Saito M. Ganglioside GM3: an acidic membrane component that increases during macrophage-like differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemic cell lines HL-60 and U937. Proc Natl Acad Sci USA 1986;83:782-6.
41. Pautrat G, Suzan M, Salaun D, et al. Human immunodeficiency virus type 1 infection of U937 cells promotes cell differentiation and a new pathway of viral assembly. Virology 1990;179:749-58.
42. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;261:1179-81.